The SCOR application process is open.
LLS’s Specialized Center of Research (SCOR) grant program is intended to bring together established investigators from one or several institutions to develop a focused research program, foster new interactions and cooperation, and enhance interdisciplinary research among the participants. The overall goal of this mechanism is to enhance the development of innovative strategies for the treatment, diagnosis or prevention of hematological malignancies. Strategies that move discoveries from the bench to the clinic are of high importance as are integrated translational projects.
Grant Terms - Specialized Center of Research
A SCOR team will be judged as a unit and funding will not be available for otherwise meritorious but non-synergistic parts of an application. The quality and significance of the Projects and Cores, and the enhanced productivity that is likely to be achieved by linking the investigators, are the primary determinants of funding decisions.
Each SCOR is comprised of a minimum of three scientific Projects and a minimum of two scientific Cores that will cooperate under the leadership of a SCOR Director. There must be objective evidence of interdisciplinary research among the Projects and Cores.
The maximal annual total cost is $1,000,000 for each year of the five year grant. The maximum annual direct cost is $833,333.33 while the maximum annual indirect cost is $166,666.66. The SCOR Director has the authority to budget these funds among the various Projects and Cores.
How to Apply/Deadlines
LLS uses its own Research Portal powered by FLUXX for Letter of Intent (LOI) and full application submission.
All times are Eastern Time (ET)
|Call for Proposals||July 2016|
|Letter of Intent Deadline||September 23, 2016||3:00 PM ET|
|Notice of Full Application Invitation||December 2016|
|Full Application Phase Deadline||March 1, 2017||3:00 PM ET|
|Notification of Awards||July 2017|
|LLS's receipt of signed contracts||September 1, 2017|
|LLS's receipt of Lay and Scientific Abstracts||September 1, 2017|
|Funding start date||October 1, 2017|
Need More Information?
Director of Research Administration
The Leukemia & Lymphoma Society
3 International Drive, Suite 200
Rye Brook, NY 10573